The Effect of Antenatal Corticosteroid on Umbilical Artery Doppler Velocimetry in IUGR

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

149 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-02-02

Study Completion Date

2019-02-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the effect of antenatal corticosteroid administration on umbilical artery Doppler velocimetry measurements in pregnancies complicated by IUGR.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Ductus Venosus Doppler in IUGR Pregnancies

NCT07193381

Intrauterine Growth Restriction (IUGR)

RECRUITING

The Effect Of Antenatal Corticosteroids On Early And Late Perinatal Outcomes

NCT06164080

Preterm Pregnancy Antenatal Corticosteroid Perinatal Problems

COMPLETED NA

Relationship of DV Doppler Parameters to Perinatal Outcomes in IUGR vs Non-IUGR

NCT07190157

Fetal Growth Restriction Perinatal Outcome Pregnancy, High Risk

NOT_YET_RECRUITING

Diagnosis and Management of Intrauterine Growth Restriction and Congenital Anomalies

NCT03398629

Intrauterine Growth Restriction Fetal Anomaly Chromosomal Anomalies +1 more

RECRUITING

Uterine Artery Diastolic Notching & Apelin-13 and 36

NCT06390202

Diagnosis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study was conducted with pregnant women who were likely to have preterm birth and were treated with antenatal corticosteroids. Betamethasone was used as an antenatal corticosteroid. UA Doppler measurements (PI, S/D ratio, RI) before antenatal corticosteroid administration and 24 and 48 hours after the last dose of corticosteroid administration were evaluated in pregnant groups complicated with IUGR and uncomplicated with IUGR and compared with each other.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intrauterine Growth Restriction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

with IUGR

Pregnant women who received antenatal corticosteroid therapy and complicated with intrauterine growth retardation

ultrasonography

Intervention Type OTHER

Umbilical artery Doppler evaluation by ultrasonography just before the first dose of antenatal corticosteroid, 24 hours and 48 hours after the last dose.

without IUGR

Pregnant women who received antenatal corticosteroid therapy and were not complicated by intrauterine growth retardation

ultrasonography

Intervention Type OTHER

Umbilical artery Doppler evaluation by ultrasonography just before the first dose of antenatal corticosteroid, 24 hours and 48 hours after the last dose.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ultrasonography

Umbilical artery Doppler evaluation by ultrasonography just before the first dose of antenatal corticosteroid, 24 hours and 48 hours after the last dose.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

pregnant women who were likely to have preterm delivery and were treated with antenatal corticosteroids.

Exclusion Criteria

Pregnant women who had complicated pregnancy with fetal anomaly, who had multiple pregnancies, who left their pregnancy follow-up unfinished, and those under 18 years of age were excluded from the study.

Minimum Eligible Age

18 Years

Maximum Eligible Age

49 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No